A USA-based private investment office makes direct investments into early stage healthcare and technology companies. The firm is active across sectors and geographies, favoring recurring revenue, capital efficiency, and durable competitive advantage. Its permanent capital base allows the team to respond to opportunities without mandate constraints or fundraising concerns.
The firm is open to sectors and subsectors in the life science space including healthcare IT, digital health, medical devices and diagnostics.
The firm is looking for companies with experienced management teams and generally looks to take a board seat following investment. Due to the firm’s capital base they can be more flexible in terms of investment timeframe and have a longer exit horizon than other investors.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Leave a Reply